Live Breaking News & Updates on ஓபியாய்டு திரும்பப் பெறுதல் நோய்க்குறி

Stay updated with breaking news from ஓபியாய்டு திரும்பப் பெறுதல் நோய்க்குறி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Indivior PLC Announcements | Indivior PLC: Half-year Report

This Release Contains Inside Information.
Comment by Mark Crossley, CEO of Indivior PLC
The second quarter saw Indivior make good progress against our Strategic Priorities and deliver strong performance, including our fourth consecutive quarter of double-digit growth from SUBLOCADE® (buprenorphine extended-release) injection. Based on the momentum in the business, we raised our FY 2021 guidance at the end of the quarter.
Looking forward, our number one priority continues to be capturing the full transformational value of SUBLOCADE, and it is gratifying to see further uptake of this key asset in targeted Organized Health Systems (OHS), including a $7 million order from a criminal justice system that we believe is pioneering treatment of incarcerated individuals suffering from opioid use disorder (OUD). Additionally, we are seeking to strengthen our leadership position in substance use disorder by securing an exclusive agreement with Aelis Far ....

New York , United States , New Zealand , United Kingdom , City Of , Mark Crossley , Jason Thompson , Jonathan Sibun , Daelis Farma , Kathryn Hudson , Office Of Inspector , Human Services , Share Repurchase Program , Indivior Group , Department Of Health , Health Systems , Tulchan Communications , Us Department Of Justice , Half Year Report , Share Repurchase , Strategic Priorities , Organized Health Systems , North America , Annual General Meeting , Use Disorder , Western Europe ,

Investegate |Indivior PLC Announcements | Indivior PLC: Indivior Raises FY 2021 Guidance

Investegate |Indivior PLC Announcements | Indivior PLC: Indivior Raises FY 2021 Guidance
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Jason Thompson , Jonathan Sibun , Kathryn Hudson , Human Services , Office Of Inspector , Indivior Group , Department Of Health , Tulchan Communications , Us Department Of Justice , Indivior Raises , Company Secretary , Inspector General , Drug Addiction Treatment , Serious Injection Site Reactions , Opioid Withdrawal Syndrome , Opioid Withdrawal With Abrupt Discontinuation , Hepatic Events , Patients Dependent , Full Agonist Opioids , Emergent Acute Pain , Prescribing Information , Medication Guide , Sublingual Film , Sublingual Tablets ,

Investegate |Indivior PLC Announcements | Indivior PLC: 1st Quarter Results

5
-

Adjusted (Adj.) basis excludes the impact of exceptional items as referenced in Notes 3 and 4.
Comment by Mark Crossley, CEO of Indivior PLC
We have seen an encouraging start in FY 2021 with growth in net revenue, operating profit and cash from execution against our strategic priorities. Despite the ongoing impacts of COVID-19, SUBLOCADE® (buprenorphine extended-release) injection achieved solid net revenue growth both on a sequential and year-over-year basis, and we expanded our Organized Health Systems (OHS) platform to build the foundation for future growth. Looking ahead, we are seeing healthcare restrictions in the US begin to ease from the rapid pace of COVID-19 vaccinations, which supports our expectation of increased in-person interactions with healthcare practitioners in the second half of the year. As such, we are reiterating our FY 2021 base case guidance. ....

City Of , United Kingdom , New York , United States , Mark Crossley , Jason Thompson , Jonathan Sibun , Department Of Justice , Office Of Inspector , Human Services , Indivior Group , Outcomes Research , Health Economics , Department Of Health , Health Systems , Tulchan Communications , Group Annual Incentive Bonus Plan , Us Department Of Justice , Organized Health Systems , Use Disorder , Western European , Executive Committee , Annual Incentive Bonus Plan , Pipeline Update , Inspector General , Sublingual Film ,